MIV-818

MIV-818 · Medivir

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MIV-818, covering 2025-07-01 to 2025-07-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations [Phase 1, Phase 2]